Cargando…
Review of potential medical treatments for middle ear cholesteatoma
Middle ear cholesteatoma (MEC), is a destructive, and locally invasive lesion in the middle ear driven by inflammation with an annual incidence of 10 per 100,000. Surgical extraction/excision remains the only treatment strategy available and recurrence is high (up to 40%), therefore developing the f...
Autores principales: | Schürmann, Matthias, Goon, Peter, Sudhoff, Holger |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487140/ https://www.ncbi.nlm.nih.gov/pubmed/36123729 http://dx.doi.org/10.1186/s12964-022-00953-w |
Ejemplares similares
-
Stem cells in middle ear cholesteatoma contribute to its pathogenesis
por: Nagel, Julia, et al.
Publicado: (2018) -
Chronic inflammation of middle ear cholesteatoma promotes its recurrence via a paracrine mechanism
por: Schürmann, Matthias, et al.
Publicado: (2021) -
Animal Models of Middle Ear Cholesteatoma
por: Yamamoto-Fukuda, Tomomi, et al.
Publicado: (2011) -
Results of endoscopic middle ear surgery
for cholesteatoma treatment: a systematic review
por: PRESUTTI, L., et al.
Publicado: (2014) -
Research Progress on Non-coding RNAs in Cholesteatoma of the Middle Ear
por: Liu, Dongliang, et al.
Publicado: (2023)